Search
for

    Sort by

    Research 451–480 of 1000+

    1. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore<sup>®</sup>, improves telogen effluvium‐associated parameters Journal of Cosmetic Dermatology · 2020 · 11 citations
    2. α<sub>1</sub>-AR agonist induced piloerection protects against the development of traction alopecia Dermatologic Therapy · 2015 · 5 citations
    3. Developing Topical Gel Formulation of Erandakarkati (Carica  papaya Linn.) Latex for Managing Indralupta: A Preliminary Study International Research Journal of Ayurveda & Yoga · 2025
    4. Tratamiento de alopecia androgenética con Sabal serrulata y péptidos biomiméticos vehiculizados con microneedling Medicina estética · 2021
    5. 181 Topical Sandalore®, a specific OR2AT4-stimulating odorant, ameliorates telogen effluvium: Randomized, double-blinded, placebo-controlled trial Journal of Investigative Dermatology · 2019
    6. Effects of Topical application of Astragalus membranaceus in Spontaneous Alopecia Mice Model 2018 · 4 citations
    7. SODIUM VALPROATE IN the TREATMENT of RESISTANT EPILEPSY Acta Neurologica Scandinavica · 1976 · 59 citations
    8. Quality of life in South African Black women with alopecia: a pilot study International Journal of Dermatology · 2015 · 16 citations
    9. Argan (Argania Spinosa) press cake extract enhances cell proliferation and prevents oxidative stress and inflammation of human dermal papilla cells Journal of dermatological science · 2021 · 14 citations
    10. Nutritive Value of Casein as Influenced by Alcohol Extraction. Experimental biology and medicine · 1948 · 4 citations
    11. Analysis of the scalp of women with AIDS subjected to autopsy: epithelial, follicular, and immunologic aspects Annals of Diagnostic Pathology · 2012 · 3 citations
    12. Vibration assisted analgesia during intralesional corticosteroid therapy for alopecia Skin health and disease · 2024 · 1 citations
    13. Efficacy of Scalp Cooling System Versus Chemical Cooling Cap in Preventing Chemotherapy-induced Alopecia in Breast Cancer (COHAIR Study): a prospective randomized trial The Breast · 2026
    14. Evaluación pronóstica de la escala delta-sofa a los 3 y 5 días del ingreso en uci asociado al saps 3 y creación de un modelo objetivo para la adecuación ética del esfuerzo terapéutico 2025
    15. Spironolactone Practical Diabetes · 2024
    16. A case of telogen effluvium associated with drug-induced hyperprolactinemia. Nihon rinsho hifukaikai zasshi · 2020
    17. Characterization of an autoimmune condition associated with AEC syndrome 2016
    18. P175 The effects of biotin supplementation on alopecia in rats which were administrated to valproic acid European journal of paediatric neurology · 2009
    19. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    20. [PRACTICAL EXPERIENCES WITH OVULATION INHIBITION]. PubMed · 1965
    21. Effects of antiandrogen therapy of cyproteron acetate on androgen effects on the skin including androgenetic alopecia in menopausal women – case report: 10 years follow up – Endocrine Abstracts · 2022
    22. The Scalp CRC Press eBooks · 2021
    23. 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia (vol 35, pg e243, 2021) Journal of The European Academy of Dermatology and Venereology · 2021
    24. A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women. PubMed · 2018 · 23 citations
    25. [Alopecia in women with severe and morbid obesity who undergo bariatric surgery]. PubMed · 2012 · 22 citations
    26. Comments regarding “Hair regrowth during chemotherapy after scalp cooling technique” International Journal of Dermatology · 2017 · 4 citations
    27. The role of mimicking growth factors to control anagen phase: Evaluation in vitro and in vivo Journal of The American Academy of Dermatology · 2010
    28. Clinical aspects of scalp cooling in chemotherapy induced alopecia 2020 · 1 citations
    29. Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin The Journal of Clinical Endocrinology & Metabolism · 2011 · 36 citations
    30. Maximum Efficacy of Finasteride Is Obtained within 6 Months and Maintained over 6 Years European Urology · 1998 · 34 citations